Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment.

Journal article

Overbeek KA. et al, (2024), Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 22, 994 - 1004.e10

Challenges and pitfalls in the diagnosis of IgG4-related disease.

Journal article

Bateman AC. and Culver EL., (2024), Seminars in diagnostic pathology, 41, 45 - 53

Fibrotic phenotype of IgG4-related disease.

Journal article

Lanzillotta M. et al, (2024), The Lancet. Rheumatology

Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?

Journal article

Jones DE. et al, (2024), Hepatology (Baltimore, Md.)

IgG4 autoantibodies and autoantigens in the context of IgG4-autoimmune disease and IgG4-related disease.

Journal article

Motta RV. and Culver EL., (2024), Frontiers in immunology, 15

Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled Trial.

Journal article

Perugino C. et al, (2023), Rheumatology and therapy

IgG4-related disease

Journal article

Nwaduru C. and Culver EL., (2023), Medicine (United Kingdom), 51, 405 - 411

UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis.

Journal article

Abbas N. et al, (2023), Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 21, 1561 - 1570.e13

Development of an algorithm for IgG4-related disease management.

Journal article

Orozco-Gálvez O. et al, (2023), Autoimmunity reviews, 22

Secondary sclerosing cholangitis and IgG4-sclerosing cholangitis - A review of cholangiographic and ultrasound imaging.

Journal article

Möller K. et al, (2023), Endoscopic ultrasound, 12, 181 - 199

Evaluation of Tofacitinib in Primary Sclerosing Cholangitis and Associated Colitis: A Multicenter, Retrospective Study.

Other

Schregel I. et al, (2023), Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Patient Priorities in Autoimmune Hepatitis: The Need for Better Treatments, More Education and Challenging Stigma.

Journal article

Lloyd C. et al, (2023), Digestive diseases and sciences, 68, 87 - 97

A novel serum metabolomic panel distinguishes IgG4‐related sclerosing cholangitis from primary sclerosing cholangitis

Journal article

Radford‐Smith DE. et al, (2022), Liver International, 42, 1344 - 1354

Blood biomarkers recommended for diagnosing and monitoring IgG4-related disease. Considerations from the ERN ReCONNET and collaborating partners.

Journal article

Iaccarino L. et al, (2022), Clinical and experimental rheumatology, 40 Suppl 134, 71 - 80

Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: a European multi-centre study.

Journal article

Ramirez GA. et al, (2022), Rheumatology (Oxford, England), 61, e109 - e111

Load More